The role of the HNF4α enhancer in type 2 diabetes variants of the HNF4α enhancer are not a common cause of susceptibility to type 2 diabetes

Molecular Genetics and Metabolism

Volumn 76, Issue 2, 2002, Pages 148-151

  Mitchell, Simon M S ^a   Gloyn, Anna L ^a   Owen, Katharine R ^a   Hattersley, Andrew T ^a   Frayling, Timothy M ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Enhancer element; Hepatic nuclear factor 4 alpha; Type 2 diabetes

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; GLUCOCORTICOID; HEPATOCYTE NUCLEAR FACTOR 3; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; NUCLEAR FACTOR I; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; HNF4A PROTEIN, HUMAN; MLX PROTEIN, HUMAN; PHOSPHOPROTEIN; TRANSCRIPTION FACTOR;

5' UNTRANSLATED REGION; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BINDING SITE; CHROMOSOME 20Q; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENHANCER REGION; GENE FREQUENCY; GENE MUTATION; GENETIC LINKAGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; CHROMOSOME 20; GENETIC VARIABILITY; GENETICS; METABOLISM; MUTATION; UNITED KINGDOM;

ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHROMOSOMES, HUMAN, PAIR 20; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GREAT BRITAIN; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LINKAGE (GENETICS); LIVER; MUTATION; PHOSPHOPROTEINS; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 0036318025     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(02)00027-6     Document Type: Article

References (32)

1. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010
2. The genetics of type 2 diabetes
3. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy
4. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene
5. Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs
6. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2
7. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population
8. Consortium. TITDLA. Lessons learned in a combined linkage analysis (24 datasets, >2000 families) of type 2 diabetes
9. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily
10. Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas
11. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism
12. Hepatic function in a family with a nonsense mutation (R154X) in the Hepatocyte Nuclear Factor-4α/MODY1 gene
13. Mutations in the hepatocyte nuclear factor4alpha gene in maturity-onset diabetes of the young (MODY1)
14. A novel Phe75fsdelT mutation in the hepatocyte nuclear factor-4alpha gene in a Danish pedigree with maturity-onset diabetes of the young
15. Mutation in the HNF-4 alpha gene affects insulin secretion and triglyceride metabolism
16. Organization and partial sequence of the hepatocyte nuclear factor-4α/MODY1 gene and identification of a missense mutation R127W, in a Japanese family with MODY
17. Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4α in Caucasians with maturity onset NIDDM
18. A missense mutation in the hepatocyte nuclear factor4alpha gene in a UK pedigree with maturity-onset diabetes of the young
19. Maturity-onset diabetes of the young: From clinical description to molecular genetic characterization
20. A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus
21. Exclusion of the Hepatocyte Nuclear Factor 4α as a candidate gene for late-onset NIDDM linked with chromosome 20q
22. An alternative splice variant of the tissue specific transcription factor
23. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young
24. A mutation of a novel splice variant of HNF4A co-segregates with maturity onset diabetes of the young (MODY)
25. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors
26. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst
27. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CII gene expression in liver and intestinal cells
28. The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids
29. Hepatocyte nuclear factor-4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis
30. Genotype/phenotype relationships in HNF-4alpha/ MODY1: Haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels
31. Parent-offspring Trios: A resource to facilitate the identification of type 2 diabetes genes
32. Mutations in hepatocyte nuclear factor1beta are not a common cause of maturity-onset diabetes of the young in the UK